AKV9, Protein Aggregation Inhibitor
Dr. P. Hande Özdinler, Associate Professor of Neurology, Feinberg School of Medicine, Northwestern University (ALS and other upper motor neuron diseases)
Dr. William Klein, Professor of Neurobiology, Professor of Neurology, Northwestern University; co-Founder, Acumen Pharmaceuticals (Alzheimer’s disease)
Dr. D. James Surmeier, Chair, Department of Neuroscience, Nathan Smith Davis Professor of Neuroscience, Feinberg School of Medicine, Northwestern University (Parkinson’s disease)
Dr. Vicki Tysseling, Assistant Professor, Department of Physical Therapy and Human Movement Sciences and Department of Neuroscience, Feinberg School of Medicine, Northwestern University (spinal cord injury)
Ornithine Aminotransferase Inactivator
Dr. Yaron Ilan, Director of Department of Medicine, Gastroenterology and Liver Units, Hebrew University-Hadassah Medical Center, Jerusalem, Israel (hepatocellular carcinoma)
Dr. Dali Liu, Professor of Chemistry, Loyola University, Chicago (protein crystallography of our inactivators bound to OAT)
Neuronal Nitric Oxide Synthase Inhibitors
Dr. Sidhartha Tan, Helppie Endowed Chair of Pediatrics, Professor of Pediatrics, Co-Chief, Division of Neonatology, Wayne State University (cerebral palsy)
Dr. D. James Surmeier, Chair, Department of Neuroscience, Nathan Smith Davis Professor of Neuroscience, Feinberg School of Medicine, Northwestern University (Parkinson’s disease)
Dr. William Klein, Professor of Neurobiology, Professor of Neurology, Northwestern University; co-Founder, Acumen Pharmaceuticals (Alzheimer’s disease)
Dr. Sun Yang, Assistant Professor, Department of Pharmacy Practice, Chapman University School of Pharmacy (melanoma)
Dr. Thomas L. Poulos, Distinguished Professor, Department of Molecular Biology and Biochemistry, Department of Pharmaceutical Sciences, Department of Chemistry, University of California, Irvine (protein crystallography of our NOS inhibitors bound to isoforms of NOS)